anonymous
Guest
anonymous
Guest
2018 might be a better idea! Maybe by then all the offices will forget what a piece of crap these products are and how horribly OraPharma launched them. It is so embarrassing at this point that my offices will probably ask me to leave if I even mention them being relaunched. Dump these products and call it quits. You have destroyed whatever momentum we had with these products. They should focus on new products and how to save Arestin.